BriaCell Therapeutics Corp (NASDAQ:BCTX) has a beta value of 1.62 and has seen 0.8 million shares traded in the last trading session. The company, currently valued at $28.32M, closed the last trade at $0.64 per share which meant it gained $0.06 on the day or 10.47% during that session. The BCTX stock price is -776.56% off its 52-week high price of $5.61 and 28.12% above the 52-week low of $0.46. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.87 million shares traded. The 3-month trading volume is 1.55 million shares.

BriaCell Therapeutics Corp (NASDAQ:BCTX) trade information

Sporting 10.47% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BCTX stock price touched $0.64 or saw a rise of 1.54%. Year-to-date, BriaCell Therapeutics Corp shares have moved 13.40%, while the 5-day performance has seen it change 19.76%. Over the past 30 days, the shares of BriaCell Therapeutics Corp (NASDAQ:BCTX) have changed -44.77%. Short interest in the company has seen 0.69 million shares shorted with days to cover at 0.77.

BriaCell Therapeutics Corp (BCTX) estimates and forecasts

Figures show that BriaCell Therapeutics Corp shares have underperformed across the wider relevant industry. The company’s shares have lost -36.56% over the past 6 months, with this year growth rate of -248.28%, compared to 16.90% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 47.85% over the past 5 years.

BCTX Dividends

BriaCell Therapeutics Corp is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.